BCL2 and diffuse large B-cell lymphoma: Using the same classification workflow, an additional, 219 unique DLBCL patients were analyzed from a publicly available DLBCL dataset (Chapuy et al.9), in which structural variants and copy number gains in MYC and BCL2 and/or BCL6 were identified (Fig. 1B, lower panel).